(Q24276425)

English

Evaluation of an inactivated Ross River virus vaccine in active and passive mouse immunization models and establishment of a correlate of protection

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

0 references

Evaluation of an inactivated Ross River virus vaccine in active and passive mouse immunization models and establishment of a correlate of protection (English)

0 references

Chikungunya virus

0 references

0 references

Ross River virus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Georg W. Holzer

1

0 references

Sogue Coulibaly

2

0 references

Gerald Aichinger

3

0 references

language of work or name

0 references

publication date

May 2011

0 references

0 references

29

0 references

24

0 references

4132-4141

0 references

Ross River virus transmission, infection, and disease: a cross-disciplinary review

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.089

7 January 2021

Clinical and pathologic aspects of arthritis due to Ross River virus and other alphaviruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.089

7 January 2021

Surveillance for Ross River virus infection using blood donors.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.089

7 January 2021

A candidate Ross River virus vaccine: preclinical evaluation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.089

7 January 2021

The preclinical testing of a formaldehyde inactivated Ross River virus vaccine designed for use in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.089

7 January 2021

Development of a candidate vaccine against Ross River virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.089

7 January 2021

Macrophage-induced muscle pathology results in morbidity and mortality for Ross River virus-infected mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.089

7 January 2021

Characterization of Ross River virus tropism and virus-induced inflammation in a mouse model of viral arthritis and myositis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.089

7 January 2021

Role of interferon and interferon regulatory factors in early protection against Venezuelan equine encephalitis virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.089

7 January 2021

A mouse model for Chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.089

7 January 2021

Alpha/beta interferon protects adult mice from fatal Sindbis virus infection and is an important determinant of cell and tissue tropism

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.089

7 January 2021

Immune response in mice that lack the interferon-gamma receptor

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.089

7 January 2021

Functional role of type I and type II interferons in antiviral defense

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.089

7 January 2021

Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.089

7 January 2021

Antibody-enhanced dengue virus infection in primate leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.089

7 January 2021

Vaccine-induced enhancement of viral infections.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.089

7 January 2021

Antibody-dependent enhancement of viral infection: molecular mechanisms and in vivo implications

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.089

7 January 2021

Ross River virus: molecular and cellular aspects of disease pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.089

7 January 2021

Antibody-dependent enhancement and persistence in macrophages of an arbovirus associated with arthritis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.089

7 January 2021

Pathogenesis of Ross River Virus Infection in Mice. I. Ependymal Infection, Cortical Thinning, and Hydrocephalus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.089

7 January 2021

Pathogenesis of Ross River Virus Infection in Mice.: II. Muscle, Heart, and Brown Fat Lesions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.089

7 January 2021

Genome sequences of a mouse-avirulent and a mouse-virulent strain of Ross River virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.089

7 January 2021

Emerging trends in plasma-free manufacturing of recombinant protein therapeutics expressed in mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.089

7 January 2021

A single mutation in chikungunya virus affects vector specificity and epidemic potential

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.089

7 January 2021

Blood volume determination in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.089

7 January 2021

Theiler's virus infection of 129Sv mice that lack the interferon alpha/beta or interferon gamma receptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.089

7 January 2021

The role of alpha/beta and gamma interferons in development of immunity to influenza A virus in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.089

7 January 2021

Safety and immunogenicity of concomitant vaccination with the cell-culture based Japanese Encephalitis vaccine IC51 and the hepatitis A vaccine HAVRIX1440 in healthy subjects: A single-blind, randomized, controlled Phase 3 study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.089

7 January 2021

Safety and immunogenicity of the modified adult tick-borne encephalitis vaccine FSME-IMMUN: results of two large phase 3 clinical studies.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.089

7 January 2021

Long-term persistence of antibodies induced by vaccination and safety follow-up, with the first combined vaccine against hepatitis A and B in children and adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.089

7 January 2021

Antibody-dependent enhancement of dengue 2 virus in people of white descent in Cuba

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.089

7 January 2021

Antibody-dependent enhancement of Murray Valley encephalitis virus virulence in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.089

7 January 2021

Live Chimeric and Inactivated Japanese Encephalitis Virus Vaccines Differ in Their Cross-Protective Values against Murray Valley Encephalitis Virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.089

7 January 2021

Identifiers

10.1016/J.VACCINE.2011.03.089

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PubMed publication ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24276425&oldid=1456574209"